The Lipid Intensive Drug Therapy for Sepsis Phase II Pilot Clinical Trial

被引:2
作者
Guirgis, Faheem W. [1 ]
Black, Lauren Page [2 ]
Henson, Morgan [2 ]
Bertrand, Andrew [1 ]
Devos, Elizabeth [2 ]
Ferreira, Jason [3 ]
Gao, Hanzhi [4 ,5 ]
Wu, Samuel S. [4 ,5 ]
Leeuwenburgh, Christiaan [6 ]
Moldawer, Lyle [7 ]
Moore, Frederick [7 ]
Reddy, Srinivasa T. [8 ]
机构
[1] Univ Florida, Coll Med, Dept Emergency Med, Gainesville, FL 32603 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL USA
[3] Univ Florida, Coll Med, Div Pulm & Crit Care Med, Dept Med, Jacksonville, FL USA
[4] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA
[5] Univ Florida, Coll Med, Gainesville, FL USA
[6] Univ Florida, Coll Med, Dept Physiol & Aging, Gainesville, FL USA
[7] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA
[8] Univ Calif Los Angeles, Dept Med, Coll Med, Los Angeles, CA USA
关键词
cholesterol; lipid emulsion; lipids; organ failure; parenteral nutrition; sepsis; septic shock; DENSITY-LIPOPROTEIN CHOLESTEROL; SEPTIC SHOCK; SURVIVAL; PROFILES; EMULSION; OUTCOMES; IMPACT; LEVEL;
D O I
10.1097/CCM.0000000000006268
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
OBJECTIVES: Low cholesterol levels in early sepsis patients are associated with mortality. We sought to test if IV lipid emulsion administration to sepsis patients with low cholesterol levels would prevent a decline or increase total cholesterol levels at 48 hours. DESIGN: Phase II, adaptive, randomized pilot clinical trial powered for 48 patients. SETTING: Emergency department or ICU of an academic medical center. PATIENTS: Sepsis patients (first 24 hr) with Sequential Organ Failure Assessment greater than or equal to 4 or shock. INTERVENTIONS: Patients meeting study criteria, including screening total cholesterol levels less than or equal to 100 mg/dL or high-density lipoprotein cholesterol (HDL-C) + low-density lipoprotein cholesterol (LDL-C) less than or equal to 70 mg/dL, were randomized to receive one of three doses of lipid emulsion administered twice in 48 hours or no drug (controls). The primary endpoint was a change in serum total cholesterol (48 hr - enrollment) between groups. MEASUREMENTS AND MAIN RESULTS: Forty-nine patients were enrolled and randomized. Two patients randomized to lipid emulsion were withdrawn before drug administration. Data for 24 control patients and 23 lipid emulsion patients were analyzed. The mean change in total cholesterol from enrollment to 48 hours was not different between groups and was 5 mg/dL (sd 20) for lipid emulsion patients, and 2 mg/dL (sd 18) for control patients (p = 0.62). The mean changes in HDL-C and LDL-C were similar between groups. Mean change in triglycerides was elevated in lipid emulsion patients (61 mg/dL, sd 87) compared with controls (20 mg/dL, sd 70, p = 0.086). The 48-hour change in SOFA score was -2 (interquartile range [IQR] -4, -1) for control patients and -2 (IQR -3, 0) for lipid emulsion patients (p = 0.46). CONCLUSIONS: Administration of IV lipid emulsion to early sepsis patients with low cholesterol levels did not influence change in cholesterol levels from enrollment to 48 hours.
引用
收藏
页码:1183 / 1193
页数:11
相关论文
共 33 条
  • [1] The effect of dietary omega-3 polyunsaturated fatty acids on plasma lipids and lipoproteins of C57BL/6 mice is age and sex specific
    Balogun, K. A.
    Randunu, R. S.
    Cheema, S. K.
    [J]. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2014, 91 (1-2): : 39 - 47
  • [2] Advancing precision medicine for acute respiratory distress syndrome
    Beitler, Jeremy R.
    Thompson, B. Taylor
    Baron, Rebecca M.
    Bastarache, Julie A.
    Denlinger, Loren C.
    Esserman, Laura
    Gong, Michelle N.
    LaVange, Lisa M.
    Lewis, Roger J.
    Marshall, John C.
    Martin, Thomas R.
    McAuley, Daniel F.
    Meyer, Nuala J.
    Moss, Marc
    Reineck, Lora A.
    Rubin, Eileen
    Schmidt, Eric P.
    Standiford, Theodore J.
    Ware, Lorraine B.
    Wong, Hector R.
    Aggarwal, Neil R.
    Calfee, Carolyn S.
    [J]. LANCET RESPIRATORY MEDICINE, 2022, 10 (01) : 107 - 120
  • [3] Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome
    Burillo, Elena
    Mateo-Gallego, Rocio
    Cenarro, Ana
    Fiddyment, Sarah
    Bea, Ana M.
    Jorge, Inmaculada
    Vazquez, Jesus
    Civeira, Fernando
    [J]. LIPIDS IN HEALTH AND DISEASE, 2012, 11
  • [4] Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo
    Cedo, Lidia
    Fernandez-Castillejo, Sara
    Rubio, Laura
    Metso, Jari
    Santos, David
    Munoz-Aguayo, Daniel
    Rivas-Urbina, Andrea
    Tondo, Mireia
    Mendez-Lara, Karen Alejandra
    Farras, Marta
    Jauhiainen, Matti
    Motilva, Maria-Jose
    Fito, Montserrat
    Blanco-Vaca, Francisco
    Sola, Rosa
    Escola-Gil, Joan Carles
    [J]. BIOMEDICINES, 2020, 8 (08)
  • [5] Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis
    Chien, JY
    Jerng, JS
    Yu, CJ
    Yang, PC
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (08) : 1688 - 1693
  • [6] Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission
    Chien, Yu-Fen
    Chen, Chung-Yu
    Hsu, Chia-Lin
    Chen, Kuan-Yu
    Yu, Chong-Jen
    [J]. JOURNAL OF CRITICAL CARE, 2015, 30 (03) : 506 - 510
  • [7] Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsis
    Cirstea, Mihai
    Walley, Keith R.
    Russell, James A.
    Brunham, Liam R.
    Genga, Kelly R.
    Boyd, John H.
    [J]. JOURNAL OF CRITICAL CARE, 2017, 38 : 289 - 294
  • [9] Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes
    Dalli, Jesmond
    Colas, Romain A.
    Quintana, Carolina
    Barragan-Bradford, Diana
    Hurwitz, Shelley
    Levy, Bruce D.
    Choi, Augustine M.
    Serhan, Charles N.
    Baron, Rebecca M.
    [J]. CRITICAL CARE MEDICINE, 2017, 45 (01) : 58 - 68
  • [10] Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial
    Dellinger, R. Phillip
    Tomayko, John F.
    Angus, Derek C.
    Opal, Steven
    Cupo, Michael A.
    McDermott, Sharon
    Ducher, Annie
    Calandra, Thierry
    Cohen, Jonathan
    [J]. CRITICAL CARE MEDICINE, 2009, 37 (11) : 2929 - 2938